Oscar Health (OSCR)
NYSE:OSCR
Want to see OSCR full AI Analyst Report?
OSCR Stock Chart & Stats
$15.63
$0.74(5.14%)
At close: 4:00 PM EST
$15.63
$0.74(5.14%)
Day’s Range― - ―
52-Week Range$10.69 - $23.80
Previous CloseN/A
Volume1.52M
Average Volume (3M)6.61M
Market Cap
$4.64B
Enterprise Value$1.71B
Total Cash (Recent Filing)$3.99B
Total Debt (Recent Filing)$430.10M
Price to Earnings (P/E)―
Beta1.07
Next Earnings
May 06, 2026EPS Estimate
1.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.24
Shares Outstanding262,157,000
10 Day Avg. Volume6,076,018
30 Day Avg. Volume6,610,515
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)3.86
Price to Sales (P/S)0.32
P/FCF Ratio3.56
Enterprise Value/Market Cap0.37
Enterprise Value/Revenue0.15
Enterprise Value/Gross Profit1.02
Enterprise Value/Ebitda-4.37
Forecast
1Y Price Target
$15.29Price Target Upside-2.18% Downside
Rating ConsensusHold
Number of Analyst Covering7
EPS Forecast (FY)0.38
Revenue Forecast (FY)$18.76B
Bulls Say, Bears Say
Bulls Say
Liquidity And FinancingA new multi-year revolving credit facility provides additional liquidity to support growth initiatives and manage market uncertainty, lowering financing risk during expansion.
Regulatory StabilityEased subsidy uncertainty and stronger integrity rules have reduced volatility in the ACA exchange market, supporting a more stable operating backdrop for insurers.
ValuationAnalyst upgraded the stock citing attractive valuation versus peers as margins recover in the ACA exchange market, which could draw investor interest.
Bears Say
Aggressive Pricing And Growth RiskPlanned rapid membership and revenue growth implies aggressive pricing that raises exposure to adverse selection and could erode margins if new members drive higher claims.
Analyst Downgrade And Model RiskAnalyst lowered the valuation multiple and assigned an Underperform rating after modeling a smaller improvement in medical loss ratio, signaling concern about sustainable margin recovery.
Medical Loss Ratio PressureA higher-than-expected medical loss ratio and an EBITDA shortfall point to rising medical costs and utilization pressures that could weaken profitability.
Oscar Health News
OSCR FAQ
What was Oscar Health’s price range in the past 12 months?
Oscar Health lowest stock price was $10.69 and its highest was $23.80 in the past 12 months.
What is Oscar Health’s market cap?
Oscar Health’s market cap is $4.64B.
When is Oscar Health’s upcoming earnings report date?
Oscar Health’s upcoming earnings report date is May 06, 2026 which is in 19 days.
How were Oscar Health’s earnings last quarter?
Oscar Health released its earnings results on Feb 10, 2026. The company reported -$1.24 earnings per share for the quarter, missing the consensus estimate of -$0.895 by -$0.345.
Is Oscar Health overvalued?
According to Wall Street analysts Oscar Health’s price is currently Overvalued.
Does Oscar Health pay dividends?
Oscar Health does not currently pay dividends.
What is Oscar Health’s EPS estimate?
Oscar Health’s EPS estimate is 1.08.
How many shares outstanding does Oscar Health have?
Oscar Health has 262,157,000 shares outstanding.
What happened to Oscar Health’s price movement after its last earnings report?
Oscar Health reported an EPS of -$1.24 in its last earnings report, missing expectations of -$0.895. Following the earnings report the stock price went up 1.738%.
Which hedge fund is a major shareholder of Oscar Health?
Currently, no hedge funds are holding shares in OSCR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Oscar Health Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$15.29 (-2.18% Downside)
$15.29 (-2.18% Downside)
Blogger Sentiment
Bullish
OSCR Sentiment 83%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 5.4M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $11.9M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.4%
Last 30 Days ▼ 1.9%
Last 30 Days ▼ 1.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
25.22%
12-Months-Change
Fundamentals
Return on Equity
-39.45%
Trailing 12-Months
Asset Growth
36.86%
Trailing 12-Months
Company Description
Oscar Health
Oscar Health, Inc. provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payor clients to engage with members and patients. It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.
OSCR Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a mix of significant near-term challenges and clear strategic progress. Oscar reported strong top-line growth (11.7B revenue, +28% YoY), record enrollment and major market share gains (17% → 30%), meaningful SG&A and AI-driven efficiencies, and provided bullish 2026 guidance including a return to profitability (operating earnings $250–$450M and revenue guidance up ~61% at midpoint). Offsetting these positives, 2025 was loss-making with high MLRs (87.4% full year, 95.4% in Q4), sizable risk-adjustment volatility including a $275M Q4 accrual, and uncertainty about how many passively-enrolled members will remain paid after subsidy expirations. Management articulated concrete levers to improve margins (pricing, product design, broker expansion, AI) and enacted capital actions to support growth. On balance, the call emphasized recovery and strong operational momentum for 2026 while acknowledging material risk-adjustment, enrollment and utilization uncertainties carried over from 2025.View all OSCR earnings summariesOSCR Stock 12 Month Forecast
Average Price Target
$15.29
▼(-2.18% Downside)
Technical Analysis
Centene
―
Humana
―
Molina Healthcare
―
Clover Health Investments
―
Alignment Healthcare
―
Ownership Overview
5.65% Insiders
15.71% Mutual Funds
0.05% Other Institutional Investors
63.55% Public Companies and Individual Investors